Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 600 of 715 entries
View as:

To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients

Phase: N/A Priority: Normal
NCT ID: NCT01023685 Org: User:
Start: 12/31/09 End: 02/29/12 Due: 02/28/13

Antiproteinuric Effect of Valsartan and Lisinopril

Phase: N/A Priority: Normal
NCT ID: NCT00171574 Org: User:
Start: 11/30/04 End: 07/31/06 Due: 07/31/07

Video Capsule Endoscopy to Investigate the Safety and Tolerability of Lumiracoxib in the Small Bowel

Phase: N/A Priority: Normal
NCT ID: NCT00350155 Org: User:
Start: 05/31/06 End: - Due: -

Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Blunt Trauma Injuries

Phase: N/A Priority: Normal
NCT ID: NCT01272947 Org: User:
Start: 01/31/11 End: 07/31/11 Due: 07/31/12

A Sub-study to LMF237A2302 to Assess the Effect of 24 Weeks Treatment With Initial Combination of Vildagliptin Plus Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00468039 Org: User:
Start: 03/06/07 End: 06/06/08 Due: 06/06/09

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of PTH134 at Increasing Doses in Healthy Postmenopausal Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00676312 Org: User:
Start: 05/31/08 End: - Due: -

Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00662649 Org: User:
Start: 02/29/08 End: 06/30/11 Due: 06/30/12

Assessment of the Skin-concentration of Vildagliptin 50 mg Every 12 Hours for 10 Days in Healthy Subjects and Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00633997 Org: User:
Start: 02/29/08 End: - Due: -

Efficacy, Safety and Pharmacokinetics of QAV680 in Asthma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00814216 Org: User:
Start: 12/31/08 End: - Due: -

A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders Patients

Phase: N/A Priority: Normal
NCT ID: NCT00219193 Org: User:
Start: 10/31/05 End: 01/31/07 Due: 01/31/08

Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density

Phase: N/A Priority: Normal
NCT ID: NCT00431444 Org: User:
Start: 01/31/07 End: 07/31/08 Due: 07/31/09

The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia.

Phase: N/A Priority: Normal
NCT ID: NCT00171457 Org: User:
Start: 04/30/05 End: 09/30/06 Due: 09/30/07

Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00413790 Org: User:
Start: 11/30/06 End: 09/30/07 Due: 09/30/08

Real-World Persistence and Adherence of Ofatumumab Compared to Self-Injectable and Oral DMTs in Patients With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT06644638 Org: User:
Start: 02/15/23 End: 10/30/23 Due: 10/30/24

To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.

Phase: N/A Priority: Normal
NCT ID: NCT00170924 Org: User:
Start: 08/31/04 End: 06/30/06 Due: 06/30/07

Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA)

Phase: N/A Priority: Normal
NCT ID: NCT00476034 Org: User:
Start: 12/31/03 End: - Due: -

Bronchodilatory Efficacy of a Single Dose QMF149 (Indacaterol Maleate/Mometasone Furoate) Via the Twisthaler® Device in Adult Patients With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00556673 Org: User:
Start: 10/31/07 End: 04/30/08 Due: 04/30/09

A Study to Evaluate the Effect of Vildagliptin on the Maximum Insulin Secretion in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00351585 Org: User:
Start: 07/31/04 End: 09/30/05 Due: 09/30/06

A Study of Three Doses of TCH346 in Patients With Early Parkinson's Disease to Evaluate Safety and Efficacy

Phase: N/A Priority: Normal
NCT ID: NCT00407212 Org: User:
Start: 01/31/02 End: 11/30/03 Due: 11/30/04

Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults

Phase: N/A Priority: Normal
NCT ID: NCT00311493 Org: User:
Start: 02/28/06 End: - Due: -

Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder

Phase: N/A Priority: Normal
NCT ID: NCT00127270 Org: User:
Start: 05/31/05 End: 02/28/06 Due: 02/28/07

Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00139594 Org: User:
Start: 12/31/04 End: 07/31/07 Due: 07/31/08

A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00170729 Org: User:
Start: 08/17/04 End: 02/28/05 Due: 02/28/06

VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil

Phase: N/A Priority: Normal
NCT ID: NCT00171015 Org: User:
Start: 12/31/04 End: 04/30/05 Due: 04/30/06

Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients Not Adequately Responding to Aliskiren Alone

Phase: N/A Priority: Normal
NCT ID: NCT00777946 Org: User:
Start: 10/31/08 End: 05/31/09 Due: 05/31/10